Effect of Glycyrrhiza glabra extract on aorta wall atherosclerotic lesion in hypercholesterolemic rabbits

Pakistan Journal of Nutrition

Volumn 6, Issue 4, 2007, Pages 313-317

  Asgary, S ^a   Jafari Dinani, N ^a   Madani, H ^a   Mahzoni, P ^b   Naderi, Gh ^a  

^a UNIVERSITY OF ISFAHAN   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Glycyrrhiza glabra; High cholesterol; Rabbit

Indexed keywords

CHOLESTEROL; GLYCYRRHIZA GLABRA EXTRACT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL DIET; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN;

GLYCYRRHIZA GLABRA; ORYCTOLAGUS CUNICULUS;

EID: 34249942216     PISSN: 16805194     EISSN: None     Source Type: Journal    
DOI: 10.3923/pjn.2007.313.317     Document Type: Article

References (15)

1. Belinky, P.A., M. Aviram, S. Mahmood and J. Vaya, 1998. Structural aspects of the inhibitory effect of glabridin on LDL oxidation. Free Rad. Biol. Med., 24: 1416-1429.
2. Braunwald, E., 1997. Hearth disease. Saunders company, philadelphia, pennsylvania, Vol 3, 1625.
3. Chekanov, V., 2003. Low frequency electrical impulses reduce atherosclerosis in cholesterol fed rabbits. Med. Sci., 9: 302-309.
4. Cooke, J.P., 1998. Nutriceuticals for cardiovascular health. Am. J. Cardiol., 82: 433-465.
5. Dobiasova, M., 2004. Atherogenic index of plasma: theoretical and practical implications. Clin. Chem., 50: 1113-1115.
6. Fuhrman, B., S. Buch, J. Vaya, P. Belinky, R. Coleman, T. Hayek and M. Aviram, 1997. Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am. J. Clin. Nutr., 66: 267-75.
7. Fuhrman, B., N. Volkova, M. Kaplan, D. Presser, J. Attias, T. Hayek and M. Aviram, 2002. Antiatherosclerotic effect of licorice extract supplementation on hypercholestrolomic patients. Nutr., 18: 268-273.
8. Lankin, V.Z., A. Tikhaze, V. Kukharchuk and Y. Belenkov, 2003. Antioxidant decrease the intensification of LDL in vivo peroxidation during therapy with statins. Mole. Cell. Biochem., 249: 126-140.
9. Moarreaf, A.R., 2004. Risk factor modification of coronary artery disease. Shiraz E-Med. J., 5: 1-7.
10. Rifai, N., P.S. Bachorik and J.J. Aibers, 1999. Lipids, Lipoproteins and apolipoproteins. In: Burtis CA, Ashwood ER, editors. Tietz Textbook of Clinical Chemistry.3th ed. Philadelphia: W. B Saunders Company: 1999, P: 809-61.
11. Rosenbla, M., P. Belinky, J. Vaya, R. Levy, T. Hayek and R. Colemani, 1999. Macrophage Enrichment with the Isoflavan Glabridin Inhibits NADPH Oxidase-induced Cell-mediated Oxidation of Low Density Lipoprotein. The American Society for Biochemistry and Molecular Biology, 274: 13790-13799.
12. Tamir, S., M. Eizenberg, D. Somjen, S. Izrael and J. Vaya, 2001. Esterogen - like activity of glabrene and other constituents isolated from licorice root. Steroid Biochemistry and Molecular Biology, 78: 291-298.
13. Uum, S.H., 2005. Liquorice and hypertension. The Netherlands J. Med., 63: 119-120.
14. Vaya, J., P.A. Belinky and M. Aviram, 1997. Antioxidant constituent from licorice roots. Free Rad. Biol. Med., 23: 302-313.
15. Wang, Z., 2001. Licorice and cancer. Nutrition and Cancer, 39: 1-11.